Jul 312026 Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing postoperative bloodbrain barrier disruption A transient, postoperative window of blood-brain barrier permeability enables repurposing of clinically used liposomal nanoparticles for glioblastoma.
